// App-Quantinova.ai

e14104 : Fosaprepitant as a risk factor for ifosfamide induced encephalopathy: A single institution experience.

Researchers

Presenter

  • Ridhi Gupta

Principal Investigators

  • Rebekah Hartwell

  • Rashmi Khanal

  • Jinayo Chen

  • Genevieve Luehrs Hayes

  • Andy Perez

  • John M. Wrangle

Medical Centers

  • Medcl Univ of South Carolina, Charleston, SC

  • Medcl Univ of South Carolina, Charleston, SC

  • Johns Hopkins University School of Medicine, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Encephalopathy

  • Solid malignancies

Biomarkers

  • Creatinine

  • Cytochrome P450 Family 3 Subfamily A Member 4

  • Human albumin

Drug/Treatment

  • Fosaprepitant

  • Ifosfamide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved